ARTICLE | Clinical News
CHMP backs approval of BioCryst's Alpivab
March 1, 2018 10:43 PM UTC
EMA's CHMP recommended approval of Alpivab peramivir from BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) to treat uncomplicated influenza. The injectable formulation of viral neuraminidase inhibitor is ...
BCIQ Company Profiles
BCIQ Target Profiles